Additional source of lignans. “Schisandrin®” has a pronounced hepatoprotective, anti-inflammatory and immunomodulatory effect, improves metabolic status, and has a multifaceted antioxidant effect.
Indications for use:
• non-alcoholic fatty liver disease (including non-alcoholic steatosis, non-alcoholic steatohepatitis with signs of liver fibrosis);
• non-alcoholic fatty liver disease in patients in combination with type II diabetes mellitus;
• toxic hepatitis (alcohol-related, drug-related, caused by taking medications);
• in patients with ineffectiveness of previously administered courses of antiviral therapy for chronic viral hepatitis B and C and as an accompanying therapy for chronic viral hepatitis B and C;
• women with polycystic ovary syndrome (PCOS) and overweight to prevent metabolic disorders.
Whey – 40.0%, potato starch – 20.0%, lactose – 19.0%, schisandrin (China) – 10.0%, MCC stabilizer – 8.0%, calcium stearate filler – 2.0%, anti-caking agent Aerosil – 1.0%.
According to published data and research conducted: “New possibilities for the treatment of non-alcoholic steatohepatitis” Fadeenko G.D., Kolesnikova O.V., Solomentseva T.A., Modern Gastroenterology, No. 1 (99), 2018; “A look at liver fibrosis in the light of understanding the modern mechanisms of its development” Kolesnikova O.V., Gastroenterology, No. 2, 2019; Dorofeev A.E., Rudenko N.N., Tkach S.M., Shvets O.V., Cheverda T.L., Gastroenterology, No. 4, 2019; “Polycystic ovary syndrome: an approach to the correction of metabolic disorders” Kalugina L.V., Tatarchuk T.F., Reproductive Endocrinology, No. 2 (52), 2020:
Schisandrin-F®is a multifunctional plant adaptogen, the active substance of which is schisandrin, a biologically active compound of the lignan group of Schisandra chinensis. Under the influence of schisandrin, the functions of hepatocytes are restored in case of liver lesions of various etiologies, the level of liver enzymes is normalized, and the activity of markers of cytolysis, cholestasis, and immune inflammation is reduced.
Adults: 1-2 tablets three times a day after meals. Do not exceed the recommended daily intake. The course of admission is 3-6 months. In the future, the duration of use should be agreed with your doctor. Before use, consultation with a doctor is recommended.
Individual sensitivity to certain components, pregnancy, lactation, children under 18, acute liver failure, decompensated liver cirrhosis. It should be indicated in case of gastritis, cholecystitis, pancreatitis with care.
18.022 kcal
Proteins – 1,01 g, carbohydrates – 3,23 g, fats – 0,118 g.
250 mg tablets N30
24 months
Manufacturing and Trading Company Farmakom Ltd
